Hypertension in the elderly patient

C Ryan1

  • 1San Francisco Heart Institute, Daly City, CA 94015.

American Heart Journal
|October 1, 1991
PubMed

Insights

Treating hypertension in elderly individuals significantly lowers cardiovascular disease and stroke risks. Ongoing trials like SHEP and STH aim to further clarify treatment benefits for isolated systolic hypertension in older adults.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Clinical Trials

Background:

  • Elderly individuals with hypertension face increased risks of cardiovascular disease and stroke.
  • Diastolic hypertension treatment in the elderly shows reduced cardiovascular morbidity.
  • Isolated systolic hypertension in older adults is strongly linked to stroke and cardiovascular mortality.

Purpose of the Study:

  • To review the impact of hypertension treatment on cardiovascular and cerebrovascular outcomes in the elderly.
  • To highlight the unique mechanisms of hypertension in older populations, such as peripheral vascular resistance.
  • To discuss ongoing research, including the Systolic Hypertension European trial and the Systolic Hypertension in the Elderly Patient trial.

Main Methods:

  • Review of existing clinical trial data on hypertension treatment in elderly patients.
  • Analysis of the relationship between isolated systolic hypertension and adverse cardiovascular and cerebrovascular events.
  • Discussion of the physiological mechanisms underlying hypertension in the elderly.

Main Results:

  • Treatment of diastolic hypertension in the elderly reduces cardiovascular morbidity.
  • Treatment in the Systolic Hypertension in the Elderly Patient pilot trial reduced stroke morbidity and mortality.
  • Isolated systolic hypertension presents a significant risk for stroke and cardiovascular disease in older adults.

Conclusions:

  • Hypertension management is crucial for reducing morbidity and mortality in elderly patients.
  • Further research from ongoing trials is needed to fully understand the treatment of isolated systolic hypertension in this population.
  • Peripheral vascular resistance is a key factor in elderly hypertension, and exercise may help reduce it.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.